Synthomer plc (LON:SYNT - Get Free Report) insider Janet E. Ashdown acquired 19,920 shares of the business's stock in a transaction dated Thursday, July 3rd. The shares were bought at an average cost of GBX 99 ($1.35) per share, for a total transaction of £19,720.80 ($26,922.59).
Synthomer Stock Down 0.5%
Shares of Synthomer stock opened at GBX 96.90 ($1.32) on Friday. The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 78.27. Synthomer plc has a 52-week low of GBX 78.20 ($1.07) and a 52-week high of GBX 296 ($4.04). The company has a market capitalization of £158.89 million, a P/E ratio of -1.94, a P/E/G ratio of -0.17 and a beta of 1.79. The company has a 50 day moving average of GBX 103.50 and a 200 day moving average of GBX 120.07.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank cut Synthomer to a "hold" rating and lowered their target price for the stock from GBX 230 ($3.14) to GBX 150 ($2.05) in a research note on Wednesday, March 12th.
Get Our Latest Stock Report on Synthomer
About Synthomer
(
Get Free Report)
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.